Jakarta, Indonesia – November 2025 – Hunan Shangcheng Biotechnology Co., Ltd. proudly participated in the 2025 Jakarta International Pet Expo, showcasing its latest innovations in companion animal healthcare. Led by Chairman Mr. Shen Haibiao, the company’s participation reflects Shangcheng’s continued commitment to expanding its presence in Southeast Asia and strengthening partnerships in the global pet healthcare market.
At the exhibition, Shangcheng presented a comprehensive portfolio of veterinary medicines for companion animals, including antiparasitic products, antibiotics, antiviral therapies, and other clinically important veterinary solutions. Among the highlights were the company’s upcoming Fluralaner Chewable Tablets and Fluralaner Spot-on Solution, developed to provide long-lasting parasite protection for dogs and cats.
Recognizing Indonesia’s rapidly growing pet market and strong demand for feline healthcare, Shangcheng also showcased products designed for the prevention and treatment of common feline diseases. These innovative solutions attracted considerable attention from local veterinarians, distributors, and industry professionals, who explored their potential applications and discussed future business opportunities.
Throughout the exhibition, Shangcheng’s booth welcomed numerous visitors seeking high-quality veterinary products and long-term cooperation. A highlight of the event was the visit of Dr. Munawaroh, President of the Indonesian Veterinary Medical Association, who met with the Shangcheng team to learn more about the company’s veterinary products and their potential applications in the Indonesian market. Following the meeting, product samples were taken for further evaluation, laying the foundation for future collaboration.
With 16 GMP-certified production lines, 7 feed additive production lines, and multiple R&D centers across China, Shangcheng Biotechnology provides comprehensive animal health solutions supported by advanced manufacturing capabilities and strict quality standards. The company remains committed to delivering safe, effective, and innovative veterinary products to customers worldwide.
Participation in the 2025 Jakarta International Pet Expo marks another important milestone in Shangcheng’s international growth strategy. Shangcheng will continue expanding its global presence, introducing innovative animal healthcare solutions to international markets, and building long-term partnerships that contribute to healthier lives for companion animals around the world.
